Nakae D, Kobayashi Y, Akai H, Andoh N, Satoh H, Ohashi K, Tsutsum

Nakae D, Kobayashi Y, Akai H, Andoh N, Satoh H, Ohashi K, Tsutsumi M, Konishi Y: Involvement of 8-hydroxyguanine formation in the initiation of rat liver carcinogenesis by low dose levels of N-nitrosodiet hylamine. Cancer Res 1997, 57: 1281–1287.PubMed 28. Ampy FR, Williams AO: Dimethylnitrosamine metabolism: I. In vitro activation of dimethylnitrosamine to mutagenic substance(s) by hepatic and renal tissues from three inbred strains of mice. Life Sci 1986, 39: 923–930.CrossRefPubMed 29. Jeong JH, An JY, Kwon YT, Rhee JG, Lee YJ: Effects of low dose quercetin: Cancer cell-specific inhibition

of learn more cell cycle progression. J Cell Biochem. 2009, 106 (1) : 73–82.CrossRefPubMed 30. Wang IK, Lin-Shiau SY, Lin JK: Induction of apoptosis by apigenin and related flavonoids through cytochrome c release and activation of caspase-9 and caspase-3 in leukaemia HL-60 cells. Eur J Cancer 1999, 35: 1517–1525.CrossRefPubMed 31. Granado-Serrano AB, Martín MA, Bravo L, Goya L, Ramos AZD5363 price S: Quercetin Induces Apoptosis via Caspase Activation, Regulation of Bcl-2, and Inhibition of PI-3-Kinase/Akt and ERK Pathways in a Human Hepatoma Cell Line (HepG2). J Nutr 2006, 136: 2715–2721.PubMed 32. Chaumontet C, Suschetet M, Honikman-Leban E, Krutovskikh VA, Berges R, Le Bon AM,

Heberden C, Shahin MM, Yamasaki H, Martel P: Lack of tumor-promoting effects of flavonoids: Studies on rat liver preneoplastic foci and on in vivo and in vitro gap junctional intercellular communication. Nutr Cancer 1996, 26: 251–263.CrossRefPubMed 33. Avila MA, Juan AV, José C, Vicente N: Quercetin Mediates the Down-Regulation of Mutant p53 in the Human Breast Cancer Cell Line MDA-MB468. Cancer Research 1994, 54: 2424–2428.PubMed 34. Takehiro E, Tang Q, Denda A, Noguchi O, Kobayashi E, Tamura K, Horiguchi K, Ogasawara H, Tsujiuchi T, Nakae D, Sugimura1 Sclareol M, KonLshi Y: Inhibition by acetylsalicylic acid, a cyclo-oxygenase inhibitor, and p-bromophenacylbromide, a phospholipase A2 inhibitor,

of both cirrhosis and enzyme-altered nodules caused by a choline-deficient, L-amino acid-defined diet in rats. Carcinogenesis 1996, 17: 467–475.CrossRef Competing interests The authors declare that they have no competing interests. Authors’ contributions AMS: Carried out the molecular genetic studies, participated in the design of the study, performed the statistical analysis, conceived of the study, and participated in its design and coordination. SSI: Carried out the immunoassays, conceived of the study and participated in its design and coordination TKE: Participated in the design of the study and performed the statistical analysis. EEH: Carried out the molecular genetic studies, participated in the design of the study, performed the statistical analysis, conceived of the study, and participated in its design and coordination.

Comments are closed.